Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials

BACKGROUND: Currently, there is no head-to-head comparison of novel pharmacological treatments for heart failure with reduced ejection fraction (HFrEF). A network meta-analysis aimed to compare effects of both conventional and alternative drug combinations on time to develop primary composite outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Suebsaicharoen, Thanakit, Chunekamrai, Puri, Yingchoncharoen, Teerapat, Tansawet, Amarit, Issarawattana, Thanaphruet, Numthavaj, Pawin, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632908/
https://www.ncbi.nlm.nih.gov/pubmed/37940331
http://dx.doi.org/10.1136/openhrt-2023-002364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632908/
https://www.ncbi.nlm.nih.gov/pubmed/37940331
http://dx.doi.org/10.1136/openhrt-2023-002364

Ejemplares similares